Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Melissa G Lechner

Showing results (31-40 of 60) with videos related to

Pageof 6
Sort By:
Thyroid : Official Journal of the American Thyroid Association|February 24, 2022
Optimal Thyroid Hormone Replacement Dose in Immune Checkpoint Inhibitor-Associated Hypothyroidism Is Distinct from Hashimoto's ThyroiditisTina Mosaferi, Karen Tsai, Samantha Sovich, et al.
Head & Neck Oncology|February 24, 2010
Establishment and characterization of a novel head and neck squamous cell carcinoma cell line USC-HN1Daniel J Liebertz, Melissa G Lechner, Rizwan Masood, et al.
Thyroid : Official Journal of the American Thyroid Association|April 14, 2018
Hypothyroidism During Tyrosine Kinase Inhibitor Therapy Is Associated with Longer Survival in Patients with Advanced Nonthyroidal CancersMelissa G Lechner, Chirag M Vyas, Ole-Petter R Hamnvik, et al.
Thyroid : Official Journal of the American Thyroid Association|April 14, 2018
Risk Factors for New Hypothyroidism During Tyrosine Kinase Inhibitor Therapy in Advanced Nonthyroidal Cancer PatientsMelissa G Lechner, Chirag M Vyas, Ole-Petter R Hamnvik, et al.
Frontiers in Immunology|July 12, 2023
Antigen presentation by clonally diverse CXCR5+ B cells to CD4 and CD8 T cells is associated with durable response to immune checkpoint inhibitorsLizhong Ding, Lu Sun, Melissa T Bu, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|March 1, 2021
Frequency of Thyroid Hormone Replacement After Lobectomy for Differentiated Thyroid CancerMax A Schumm, Melissa G Lechner, Michelle L Shu, et al.
Biorxiv : the Preprint Server for Biology|January 23, 2024
A pathologically expanded, clonal lineage of IL-21 producing CD4+ T cells drives Inflammatory neuropathyMaryamsadat Seyedsadr, Madison Bang, Ethan McCarthy, et al.
Thyroid : Official Journal of the American Thyroid Association|January 13, 2016
Circulating Myeloid-Derived Suppressor Cells Predict Differentiated Thyroid Cancer Diagnosis and ExtentTrevor E Angell, Melissa G Lechner, Alison M Smith, et al.
Plastic and Reconstructive Surgery|December 10, 2014
Anaplastic large cell lymphoma occurring in women with breast implants: analysis of 173 casesGarry S Brody, Dennis Deapen, Clive R Taylor, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 14, 2012
Survival signals and targets for therapy in breast implant-associated ALK--anaplastic large cell lymphomaMelissa G Lechner, Carolina Megiel, Connor H Church, et al.
Pageof 6

Showing results (31-40 of 60) with videos related to

Sort By:
Pageof 6
Thyroid : Official Journal of the American Thyroid Association|February 24, 2022
Optimal Thyroid Hormone Replacement Dose in Immune Checkpoint Inhibitor-Associated Hypothyroidism Is Distinct from Hashimoto's ThyroiditisTina Mosaferi, Karen Tsai, Samantha Sovich, et al.
Head & Neck Oncology|February 24, 2010
Establishment and characterization of a novel head and neck squamous cell carcinoma cell line USC-HN1Daniel J Liebertz, Melissa G Lechner, Rizwan Masood, et al.
Thyroid : Official Journal of the American Thyroid Association|April 14, 2018
Hypothyroidism During Tyrosine Kinase Inhibitor Therapy Is Associated with Longer Survival in Patients with Advanced Nonthyroidal CancersMelissa G Lechner, Chirag M Vyas, Ole-Petter R Hamnvik, et al.
Thyroid : Official Journal of the American Thyroid Association|April 14, 2018
Risk Factors for New Hypothyroidism During Tyrosine Kinase Inhibitor Therapy in Advanced Nonthyroidal Cancer PatientsMelissa G Lechner, Chirag M Vyas, Ole-Petter R Hamnvik, et al.
Frontiers in Immunology|July 12, 2023
Antigen presentation by clonally diverse CXCR5+ B cells to CD4 and CD8 T cells is associated with durable response to immune checkpoint inhibitorsLizhong Ding, Lu Sun, Melissa T Bu, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|March 1, 2021
Frequency of Thyroid Hormone Replacement After Lobectomy for Differentiated Thyroid CancerMax A Schumm, Melissa G Lechner, Michelle L Shu, et al.
Biorxiv : the Preprint Server for Biology|January 23, 2024
A pathologically expanded, clonal lineage of IL-21 producing CD4+ T cells drives Inflammatory neuropathyMaryamsadat Seyedsadr, Madison Bang, Ethan McCarthy, et al.
Thyroid : Official Journal of the American Thyroid Association|January 13, 2016
Circulating Myeloid-Derived Suppressor Cells Predict Differentiated Thyroid Cancer Diagnosis and ExtentTrevor E Angell, Melissa G Lechner, Alison M Smith, et al.
Plastic and Reconstructive Surgery|December 10, 2014
Anaplastic large cell lymphoma occurring in women with breast implants: analysis of 173 casesGarry S Brody, Dennis Deapen, Clive R Taylor, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 14, 2012
Survival signals and targets for therapy in breast implant-associated ALK--anaplastic large cell lymphomaMelissa G Lechner, Carolina Megiel, Connor H Church, et al.
Pageof 6